Manager TitleAgeSince
Chief Executive Officer 49 2025-05-30
Director of Finance/CFO 61 2025-05-30
Sales & Marketing 53 2023-12-31
Director TitleAgeSince
Director/Board Member 62 2019-12-31
Chairman 42 2025-05-31
Director/Board Member 75 2025-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-35.15%-30.97% - - 717K
+2.67%-1.17%-25.63%+4.65% 169B
+1.84%-0.76%-9.96%+15.34% 110B
+3.55%+4.72%-23.02%+7.15% 106B
+1.19%+0.42%-48.90%-11.41% 73.87B
+1.90%+2.61%+4.02%+72.41% 58.98B
+1.32%+4.32%+14.41%+64.37% 51.28B
+2.19%-1.71%-6.68%-30.44% 48.16B
+1.67%+1.50%-16.50%+21.67% 40.84B
+1.80%+0.32%+29.60%-0.91% 32.21B
Average -1.89%-0.86%-9.18%+15.87% 76.69B
Weighted average by Cap. +1.75%-1.30%-15.26%+13.55%
Logo ProstaLund AB
ProstaLund AB is a Sweden-based company that provides health care products and services. The Company develops and manufactures urological devices and treatments primarily for benign prostatic hyperplasia (BPH). The Company develops CoreTherm, a patented Thermotherapy treatment method for BPH, which takes approximately 6-15 minutes and offers long-term symptom relief. CoreTherm is used in hospitals and clinics in Sweden and worldwide.
Employees
6
  1. Stock Market
  2. Stocks
  3. PLUN Stock